References
- Serruys PW, de Jaegere P, Kiemeneij F et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. BENESTENT Study Group. N. Engl. J. Med.331, 489–495 (1994).
- Fischman DL, Leon MB, Baim DS et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N. Engl. J. Med.331, 496–501 (1994).
- Holmes DR Jr, Savage M, LaBlanche JM et al. Results of Prevention of Restenosis with Tranilast and its Outcomes (PRESTO) trial. Circulation106, 1243–1250 (2002).
- Sousa JE, Costa MA, Abizaid A et al. Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation103, 192–195 (2001).
- Sousa JE, Costa MA, Abizaid AC et al. Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up. Circulation104, 2007–2011 (2001).
- Garg S, Serruys PW. Coronary stents: current status. J. Am. Coll. Cardiol.56, S1–S42 (2010).
- Lambert ND, Applegate RJ. The comparative safety of bare-metal and drug-eluting intracoronary stents. Expert Rev Med Devices.7, 611–624 (2010).
- Garg S, Serruys PW. Coronary stents: looking forward. J. Am. Coll. Cardiol.56, S43–S78 (2010).
- Kim YH, Lee CW, Hong MK et al. Randomized comparison of carbon ion-implanted stent versus bare metal stent in coronary artery disease: the Asian Pacific Multicenter Arthos Stent Study (PASS) trial. Am. Heart J.149, 336–341 (2005).
- Karjalainen PP, Annala AP, Ylitalo A, Vahlberg T, Airaksinen KE. Long-term clinical outcome with titanium-nitride-oxide-coated stents and paclitaxel-eluting stents for coronary revascularization in an unselected population. Int. J. Cardiol.144, 42–46 (2010).
- Karjalainen PP, Ylitalo A, Airaksinen JK, Nammas W. Titanium-nitride-oxide-coated Titan-2 bioactive coronary stent: a new horizon for coronary intervention. Expert Rev. Med. Devices7, 599–604 (2010).
- Kastrati A, Mehilli J, Dirschinger J et al. Intracoronary Stenting and Angiographic Results: Strut Thickness Effect on Restenosis Outcome (ISAR-STEREO) trial. Circulation103, 2816–2821 (2001).
- Pache J, Kastrati A, Mehilli J et al. Intracoronary Stenting and Angiographic Results: Strut Thickness Effect on Restenosis Outcome (ISAR-STEREO-2) trial. J. Am. Coll. Cardiol.41, 1283–1288 (2003).
- Briguori C, Sarais C, Pagnotta P et al. In-stent restenosis in small coronary arteries: impact of strut thickness. J. Am. Coll. Cardiol.40, 403–409 (2002).
- Legrand V, Kelbaek H, Hauptmann KE et al. Clinical and angiographic analysis with a cobalt alloy coronary stent (Driver) in stable and unstable angina pectoris. Am. J. Cardiol.97, 349–352 (2006).
- Sketch MH Jr, Ball M, Rutherford B, Popma JJ, Russell C, Kereiakes DJ. Evaluation of the Medtronic (Driver) cobalt–chromium alloy coronary stent system. Am. J. Cardiol.95, 8–12 (2005).
- Kandzari DE, Leon MB, Popma JJ et al. Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: a randomized controlled trial. J. Am. Coll. Cardiol.48, 2440–2447 (2006).
Website
- Medtronic Vascular. Medtronic Coronary Stent Systems: Clinical programs. Medtronic Vascular, CA, USA (2010) www.endeavorstent.com